221 related articles for article (PubMed ID: 17250787)
1. Oral colon delivery: rationale and time-based drug design strategy.
Gazzaniga A; Maroni A; Foppoli A; Palugan L
Discov Med; 2006 Dec; 6(36):223-8. PubMed ID: 17250787
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
3. Targeting drugs to the colon: delivery systems for oral administration.
Ashford M; Fell JT
J Drug Target; 1994; 2(3):241-57. PubMed ID: 7812693
[TBL] [Abstract][Full Text] [Related]
4. Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update.
Dahan A; Amidon GL; Zimmermann EM
Expert Rev Clin Immunol; 2010 Jul; 6(4):543-50. PubMed ID: 20594127
[TBL] [Abstract][Full Text] [Related]
5. Oral colon delivery of insulin with the aid of functional adjuvants.
Maroni A; Zema L; Del Curto MD; Foppoli A; Gazzaniga A
Adv Drug Deliv Rev; 2012 May; 64(6):540-56. PubMed ID: 22086142
[TBL] [Abstract][Full Text] [Related]
6. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
Asghar LF; Chandran S
J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
[TBL] [Abstract][Full Text] [Related]
7. Colonic drug targeting.
Kinget R; Kalala W; Vervoort L; van den Mooter G
J Drug Target; 1998; 6(2):129-49. PubMed ID: 9886237
[TBL] [Abstract][Full Text] [Related]
8. Colonic drug delivery: an updated review.
Shareef MA; Khar RK; Ahuja A; Ahmad FJ; Raghava S
AAPS PharmSci; 2003; 5(2):E17. PubMed ID: 12866944
[TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
10. Oral pulsatile delivery: rationale and chronopharmaceutical formulations.
Maroni A; Zema L; Del Curto MD; Loreti G; Gazzaniga A
Int J Pharm; 2010 Oct; 398(1-2):1-8. PubMed ID: 20655998
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
Goto T; Tanida N; Yoshinaga T; Sato S; Ball DJ; Wilding IR; Kobayashi E; Fujimura A
J Control Release; 2004 May; 97(1):31-42. PubMed ID: 15147802
[TBL] [Abstract][Full Text] [Related]
12. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
13. Cutting-edge technologies in colon-targeted drug delivery systems.
Patel MM
Expert Opin Drug Deliv; 2011 Oct; 8(10):1247-58. PubMed ID: 21933030
[TBL] [Abstract][Full Text] [Related]
14. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.
Chuong MC; Christensen JM; Ayres JW
Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272
[TBL] [Abstract][Full Text] [Related]
15. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
16. Time-controlled oral delivery systems for colon targeting.
Gazzaniga A; Maroni A; Sangalli ME; Zema L
Expert Opin Drug Deliv; 2006 Sep; 3(5):583-97. PubMed ID: 16948555
[TBL] [Abstract][Full Text] [Related]
17. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Sudhakar Y; Kuotsu K; Bandyopadhyay AK
J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
[TBL] [Abstract][Full Text] [Related]
18. New oral delivery systems for treatment of inflammatory bowel disease.
Friend DR
Adv Drug Deliv Rev; 2005 Jan; 57(2):247-65. PubMed ID: 15555741
[TBL] [Abstract][Full Text] [Related]
19. Strategies to improve oral drug bioavailability.
Gomez-Orellana I
Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
[TBL] [Abstract][Full Text] [Related]
20. [Site-specific drug delivery systems. I. Colon targeted delivery].
Szente V; Zelkó R
Acta Pharm Hung; 2007; 77(3):185-9. PubMed ID: 18019784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
